Last week, a federal judge in Texas finally made a highly anticipated ruling that could block access to mifepristone — one of the two drugs used in the recommended medication abortion regimen — as soon as this Friday. Yet a separate ruling made by a federal judge in Washington state could protect access to the drug. The conflicting messages from two separate federal judges could lead to a confusing situation regarding the accessibility of medication abortions.
"They're incredibly in conflict with each other," David S. Cohen, a professor of law at Drexel Kline's School of Law, told Salon.
